Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension

被引:25
作者
Baszczuk, Aleksandra [1 ]
Musialik, Katarzyna [2 ]
Kopczynski, Jaroslaw [2 ]
Thielemann, Anna [1 ]
Kopczynski, Zygmunt [1 ]
Kesy, Lena [1 ]
Dopierala, Gabriela [1 ]
机构
[1] Poznan Univ Med Sci, Dept Lab Diagnost, PL-60569 Poznan, Poland
[2] Poznan Univ Med Sci, Dept Internal Med Metab Disorders & Hypertens, PL-60569 Poznan, Poland
来源
ADVANCES IN MEDICAL SCIENCES | 2014年 / 59卷 / 01期
关键词
Hypertension; Hyperhomocysteinemia; Cholesterol; Triglycerides; Apolipoprotein; SMOOTH-MUSCLE-CELLS; PLASMA TOTAL HOMOCYSTEINE; HIGH-DENSITY-LIPOPROTEIN; ISCHEMIC-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTOR; CORONARY ATHEROSCLEROSIS; SERUM HOMOCYSTEINE; NITRIC-OXIDE; HOMOCYST(E)INE;
D O I
10.1016/j.advms.2013.08.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purposes: The main aim of the study was to answer two questions: what are the concentrations of total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, apo A-I (apolipoprotein A-I), apo B (apolipoprotein B) and Lp(a) (lipoprotein(a)) in serum of patients with primary hypertension and with hyperhomocysteinemia? Is there any correlation between the concentration of homocysteine in blood serum and investigated lipid and lipoprotein parameters in patients with primary hypertension? Material/ methods: We investigated 42 patients with primary hypertension, aged 22-57. The control group consisted of 20 healthy volunteers. The concentration of homocysteine in serum was evaluated using immunochemical method (FPIA -Fluorescence Polarization Immunoassay). The concentration of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides in blood serum were estimated using enzymatic method. Apo A-I, apo B and lipoprotein(a) were assessed using nephelometric method. Results: The analysis of the results revealed statistically significant lower concentrations of HDLcholesterol and apo A-I in blood serum of patients with primary hypertension and hyperhomocysteinemia than in the population with hypertension and normohomocysteinemia. Negative correlation between homocysteine and HDL-cholesterol as well as apo A-I has been revealed. Conclusion: Quantitative analysis of the concentration of lipids and lipoproteins in blood serum in patients with primary hypertension and hyperhomocysteinemia may suggest that this type of human population might be more susceptible to atherosclerosis than those with primary hypertension and normal values of homocysteine. (C) 2014 Medical University of Bialystok. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 44 条
[1]   NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[2]  
[Anonymous], 2007, VASC HLTH RISK MANAG, V3, P783
[3]   Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials [J].
Antoniades, Charalambos ;
Antonopoulos, Alexios S. ;
Tousoulis, Dimitris ;
Marinou, Kyriakoula ;
Stefanadis, Christodoulos .
EUROPEAN HEART JOURNAL, 2009, 30 (01) :6-15
[4]  
Asfar S, 2007, J CARDIOVASC SURG, V48, P601
[5]   Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over [J].
Bates, CJ ;
Mansoor, MA ;
vanderPols, J ;
Prentice, A ;
Cole, TJ ;
Finch, S .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1997, 51 (10) :691-697
[6]  
Bogdanski P, 2011, OBES REV S1, V12, P199
[7]   Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques [J].
Burke, AP ;
Fonseca, V ;
Kolodgie, F ;
Zieske, A ;
Fink, L ;
Virmani, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (11) :1936-1941
[8]   Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management [J].
Chapman, M. John ;
Ginsberg, Henry N. ;
Amarenco, Pierre ;
Andreotti, Felicita ;
Boren, Jan ;
Catapano, Alberico L. ;
Descamps, Olivier S. ;
Fisher, Edward ;
Kovanen, Petri T. ;
Kuivenhoven, Jan Albert ;
Lesnik, Philippe ;
Masana, Luis ;
Nordestgaard, Borge G. ;
Ray, Kausik K. ;
Reiner, Zeljko ;
Taskinen, Marja-Riitta ;
Tokgozoglu, Lale ;
Tybjaerg-Hansen, Anne ;
Watts, Gerald F. .
EUROPEAN HEART JOURNAL, 2011, 32 (11) :1345-1361
[9]   Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis [J].
Clarke, R ;
Collins, R ;
Lewington, S ;
Donald, A ;
Alfthan, G ;
Tuomilehto, J ;
Arnesen, E ;
Bonaa, K ;
Blacher, J ;
Boers, GHJ ;
Bostom, A ;
Bots, ML ;
Grobee, DE ;
Brattström, L ;
Breteler, MMB ;
Hofman, A ;
Chambers, JC ;
Kooner, JS ;
Coull, BM ;
Evans, RW ;
Kuller, LH ;
Evers, S ;
Folsom, AR ;
Freyburger, G ;
Parrot, F ;
Genst, J ;
Dalery, K ;
Graham, IM ;
Daly, L ;
Hoogeveen, EK ;
Kostense, PJ ;
Stehouwer, CDA ;
Hopknis, PN ;
Jacques, P ;
Selhub, J ;
Luft, FC ;
Jungers, P ;
Lindgren, A ;
Lolin, YI ;
Loehrer, F ;
Fowler, B ;
Mansoor, MA ;
Malinow, MR ;
Ducimetiere, P ;
Nygard, O ;
Refsum, H ;
Vollset, SE ;
Ueland, PM ;
Omenn, GS ;
Beresford, SAA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2015-2022
[10]   Homocysteine increases the risk associated with hyperlipidaemia [J].
Daly, Caroline ;
Fitzgerald, Anthony R. ;
O'Callaghan, Patrick ;
Collins, Patrick ;
Cooney, Marie Therese ;
Graham, Ian M. .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (02) :150-155